These facts paved the way for the development of a GIP receptor agonist-based therapy for T2DM, looking also for the possibility of finding a dual GLP-1/GIP receptor agonist [17]
GLP-1 Trends GLP-1s are a class of medications originally approved for type 2 diabetes management that have seen dramatic growth in prescribing following expanded approvals for chronic weight management
You can take the injection on your belly, outer thighs, upper buttocks and the backs of your arms
Adjunct options like evidence-backed nutraceuticals or targeted supplementation can assist without the complexity of stacks
Most individuals who experience significant nausea in the first month find it substantially improved by months two and three
Phase 3 data from the ATTAIN-1 trial, which evaluated 3,127 adults with obesity over 72 weeks, showed a mean weight loss of 11.2%, with more than half of participants achieving at least 10% body weight reduction
